Search results
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 24 cents per share for second-quarter 2022, wider than the...
ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) delivered earnings and revenue surprises of -19.23% and 30.16%, respectively, for...
Immunogen (IMGN) Provides Preliminary Data on Rare Blood Cancer Candidate
Zacks via Yahoo Finance· 2 years agoImmunoGen IMGN provided an update on its pivotal phase II CADENZA study, evaluating its...
Immunogen Inc (IMGN) Reports Q3 2023 Earnings: Net Income of $30.7 Million
GuruFocus.com via Yahoo Finance· 8 months agoImmunogen Inc (NASDAQ:IMGN) reported a net income of $30.7 million for Q3 2023, compared to a net...
With 72% institutional ownership, ImmunoGen, Inc. (NASDAQ:IMGN) is a favorite amongst the big guns
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in ImmunoGen, Inc. (NASDAQ:IMGN) should be aware of the most powerful shareholder...
ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing
Benzinga via Yahoo Finance· 1 year agoImmunoGen Inc (NASDAQ: IMGN) announced a global, multi-target license and option agreement that...
Are Investors Undervaluing ImmunoGen, Inc. (NASDAQ:IMGN) By 38%?
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights The projected fair value for ImmunoGen is US$47.87 based on 2 Stage Free Cash Flow to...
ImmunoGen (IMGN) Down 16.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for ImmunoGen (IMGN). Shares have lost about...
All You Need to Know About ImmunoGen (IMGN) Rating Upgrade to Strong Buy
Zacks via Yahoo Finance· 6 months agoImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects, which is...
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
Motley Fool via Yahoo Finance· 6 months agoDrug patents don't last forever, so pharmaceutical companies are constantly looking for the next big...